FDA Approves Menstrual Treatment
The Food and Drug Administration has approved the Genesys HTA System of Boston Scientific Corp. for treatment of menorrhagia, or abnormally heavy and prolonged menstrual bleeding.
The Food and Drug Administration has approved the Genesys HTA System of Boston Scientific Corp. for treatment of menorrhagia, or abnormally heavy and prolonged menstrual bleeding.
The system includes a hardware and software unit that controls the procedure through tubing and a sheath of heated saline solution to the endometrial (interior) lining of the uterus.
The procedure can be done in a hospital outpatient setting under general anesthesia or a physician office using a local anesthetic.
An estimated 10 million women in the United States have menorrhagia, according to the Natick, Mass.-based vendor. More information is available at bostonscientific.com.
--Joseph Goedert
The system includes a hardware and software unit that controls the procedure through tubing and a sheath of heated saline solution to the endometrial (interior) lining of the uterus.
The procedure can be done in a hospital outpatient setting under general anesthesia or a physician office using a local anesthetic.
An estimated 10 million women in the United States have menorrhagia, according to the Natick, Mass.-based vendor. More information is available at bostonscientific.com.
--Joseph Goedert
More for you
Loading data for hdm_tax_topic #better-outcomes...